Evidence Catalog

Block 9

February 24, 2020

HypoEXIT Trial: Lower versus Traditional Treatment Threshold for Neonatal Hypoglycemia

 More 

  • The HypoEXIT trial was a randomized controlled noninferioty trial comparing neurodevelopmental outcomes at 18 months for newborns who are treated at a traditional hypoglycemia threshold of 47 versus a lower threshold of 36 mg/dL.
  • The study found that Bayley Scores of Infant and Toddler Development for cognitive and motor domains were not different between the traditional threshold and lower threshold groups.
  • This aligns with the LPCH Newborn Nursery Asymptomatic Hypoglycemia Protocol, which uses 35 as the threshold for the initial feed after birth and 45 as the threshold for subsequent feeds for the first 24 hours of life.

 Less 

Example Citation

 More 

In The New England Journal of Medicine from 2020, the HypoEXIT trial showed that a BG threshold of 36 was non-inferior to a threshold of 47 when comparing developmental outcomes at 18 months. This evidence supports a hypoglycemia algorithm that balances expectant monitoring and treatment.

 Less